Transferring Spectral Flow Cytometry Panels to the ID7000: Performance and Unmixing Considerations

Webinar - Transferring Spectral Flow Cytometry Panels to the ID7000: Performance and Unmixing Considerations

Date: Wednesday, January 28, 2026 at 8:00 PST | 11:00 EST | 16:00 GMT | 17:00 CET

Flow cytometry panels are often developed on a specific instrument configuration, raising questions about performance when transferred to a different platform. In this webinar, we demonstrate the successful transfer of a multicolor spectral panel that was not originally designed for the ID7000™ Spectral Cell Analyzer from Sony Biotechnology. We show that equivalent data quality and resolution can be achieved.

Using real experimental data, we explore differences in spread and resolution between 5-laser and 6-laser configurations. Also, we assess the impact of unmixing strategy with optional examples using beads and cells. Attendees will gain practical insight into panel portability and unmixing best practices.

Learning Objectives:

Who should attend

This webinar is intended for flow cytometry users working with multicolor or spectral panels. Researchers considering panel transfer between platforms, core facility staff, and scientists interested in optimizing unmixing and instrument configuration choices will benefit from this presentation.

Register Now

Speaker

Dr. Pratip Chattopadhyay
Founder and CEO
Talon Biomarkers

Dr. Chattopadhyay is a leader in immunology and cytometry, known for his groundbreaking work in developing advanced assays and bioinformatics tools. Talon Biomarkers provides cutting-edge immune monitoring services across various biomedical disciplines. Dr. Chattopadhyay’s expertise in high-parameter cytometry technologies drives innovative research that aids in predicting patient outcomes, understanding disease pathogenesis, and designing effective drug therapies.

Dr. Chattopadhyay has been Associate Editor for the journal Cytometry, a former council member of ISAC, and the Scientific Chair for CYTO2019. He holds a PhD from the Johns Hopkins Bloomberg School of Public Health and a BA from the University of Virginia..